SelectQuote, Inc. (NYSE:SLQT) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of SelectQuote, Inc. (NYSE:SLQTGet Free Report) have earned an average recommendation of “Moderate Buy” from the five brokerages that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a strong buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $2.9167.

Several research firms have recently weighed in on SLQT. Craig Hallum set a $3.00 target price on SelectQuote in a research report on Friday, February 6th. Weiss Ratings downgraded shares of SelectQuote from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Tuesday, March 3rd. Zacks Research upgraded shares of SelectQuote from a “hold” rating to a “strong-buy” rating in a report on Friday, February 6th. Royal Bank Of Canada decreased their price target on shares of SelectQuote from $5.00 to $3.00 and set a “sector perform” rating for the company in a research note on Wednesday, February 11th. Finally, Wall Street Zen raised SelectQuote from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th.

Check Out Our Latest Stock Report on SLQT

Institutional Trading of SelectQuote

Hedge funds have recently added to or reduced their stakes in the business. GatePass Capital LLC raised its stake in SelectQuote by 150.6% in the first quarter. GatePass Capital LLC now owns 526,700 shares of the company’s stock worth $332,000 after buying an additional 316,500 shares in the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of SelectQuote by 1,166.2% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 51,599 shares of the company’s stock worth $73,000 after acquiring an additional 47,524 shares in the last quarter. Aristides Capital LLC purchased a new stake in shares of SelectQuote during the 4th quarter worth $108,000. Invesco Ltd. boosted its position in SelectQuote by 12.0% during the fourth quarter. Invesco Ltd. now owns 265,687 shares of the company’s stock valued at $375,000 after purchasing an additional 28,441 shares in the last quarter. Finally, Empowered Funds LLC purchased a new position in SelectQuote in the fourth quarter valued at about $628,000. 34.59% of the stock is owned by hedge funds and other institutional investors.

SelectQuote Stock Down 3.6%

Shares of NYSE SLQT opened at $1.20 on Thursday. SelectQuote has a 1 year low of $0.56 and a 1 year high of $2.80. The firm has a 50-day simple moving average of $0.75 and a two-hundred day simple moving average of $1.22. The company has a market cap of $210.67 million, a P/E ratio of 13.28 and a beta of 1.62. The company has a debt-to-equity ratio of 0.92, a current ratio of 5.63 and a quick ratio of 5.65.

SelectQuote (NYSE:SLQTGet Free Report) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.17. SelectQuote had a return on equity of 20.49% and a net margin of 5.60%.The firm had revenue of $430.93 million for the quarter, compared to the consensus estimate of $438.93 million. Research analysts anticipate that SelectQuote will post -0.14 earnings per share for the current year.

About SelectQuote

(Get Free Report)

SelectQuote, Inc (NYSE: SLQT) is a U.S.-based insurance brokerage and lead generation company that connects consumers with a range of insurance products through proprietary technology and licensed agents. The company specializes in life insurance, supplemental health coverage and Medicare plans, leveraging its digital platform and call center operations to help individuals compare policies and find cost-effective solutions tailored to their needs.

Through a single point of contact, policy seekers can evaluate offerings from multiple carriers, including term life, whole life, accidental death, critical illness and long-term care products.

Read More

Analyst Recommendations for SelectQuote (NYSE:SLQT)

Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.